Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Manchester Featured PhD Programmes
University of Sussex Featured PhD Programmes
University of Glasgow Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
University of Reading Featured PhD Programmes
"alzheimer"×
10 miles

alzheimer PhD Projects, Programs & Scholarships

We have 68 alzheimer PhD Projects, Programs & Scholarships

  • "alzheimer" ×
  • clear all
Order by 
Showing 1 to 10 of 68
  The emerging role of RAS in Alzheimer’s disease and dementia
  Prof P Kehoe, Dr S Miners
Applications accepted all year round
The Dementia Research Group at Bristol is the most widely published group and thus to the forefront of the emerging involvement of the renin angiotensin system (RAS) in the pathology of Alzheimer’s disease (AD).
  Understanding how age and gender influence the development of Alzheimer’s disease
  Dr E Kidd
Applications accepted all year round
Alzheimer’s disease is a progressive, incurable, neurodegenerative disease. It is characterised by increasing memory loss and is associated with very high socioeconomic costs.
  Identifying glucose-dependent mechanisms underlying risk factors for Alzheimer’s disease
  Research Group: Pharmacology and Experimental Therapeutics
  Dr R Williamson, Dr S McLean
Applications accepted all year round
Several risk factors for Alzheimer’s disease including diabetes and midlife obesity are age-dependent and have an obvious metabolic component resulting in impaired glucose metabolism.
  Alzheimer’s Society Doctoral Training Centre PhD Studentship: Knowing where: spatial processing in young and old ApoE4 carriers
  Dr C Bird
Application Deadline: 7 February 2019
This studentship is part of the Alzheimer’s Society Doctoral Training Centre at Sussex whose programme of research focuses on understanding a risk gene for Alzheimer’s, APOE4, and its effects throughout life.
  Self-association of the Alzheimer’s peptide Aβ on membrane surfaces
  Prof M P Williamson
Applications accepted all year round
Alzheimer’s disease is a neurodegenerative disease that is particularly common amongst the elderly. It accounts for about 65% of all cases of dementia, and affects about 6% of people over 65, rising to 50% of people over 85.
  Investigating the links between osteoporosis & Alzheimer’s disease – effects of β-amyloid upon the mechanical set-point in bone
  Dr S McArthur, Dr SCF Rawlinson
Applications accepted all year round
Background. Individuals with Alzheimer’s disease are more likely to suffer from osteoporosis (the loss of bone mass and strength) than age-matched individuals; significantly contributing to the frailty associated with dementia.
  Determining brain glycosylation in ageing and Alzheimer’s disease
  Research Group: Pharmacology and Experimental Therapeutics
  Dr R Williamson, Dr C Sutton
Applications accepted all year round
Increasing age is associated with lower levels of cognitive performance; concomitant with this is a decrease in brain glucose metabolism.
  Capturing how Hsp90 prevents the formation of cell-disruptive toxic amyloid species by Cryo-EM in a C. elegans model for Alzheimer’s Disease
  Research Group: BBSRC White Rose DTP
  Dr P van Oosten-Hawle, Prof N A Ranson, Dr E W Hewitt
Application Deadline: 7 January 2019
Stress and aging challenge the health of a proteome and increase susceptibility to protein conformational diseases, a hallmark of many neurodegenerative diseases, including Alzheimer’s Disease.
  MRC DiMeN Doctoral Training Partnership: Waking up to neurodegenerative diseases: development of an awake mouse preparation to investigate neurovascular dysfunction in ageing and Alzheimer’s disease
  Dr C Howarth, Dr J Berwick
Application Deadline: 21 January 2019
To maintain healthy brain function, local cerebral blood flow must be matched to neuronal metabolic demand through a dynamic relationship termed neurovascular coupling.
  Risk prediction of time to onset of Alzheimer’s disease using imaging modalities within DPUK
  Dr S White, Dr B Tom
Application Deadline: 3 January 2019
Predicting the time to onset of Alzheimer’s disease is challenging, but predictions will help to identify patients at risk and help to identify patients that may benefit from new developments in care and treatment.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.